3H-imidazo[4,5-b]pyridine-2-carboxylic acid

3H-imidazo[4,5-b]pyridine-2-carboxylic acid Struktur
97640-15-8
CAS-Nr.
97640-15-8
Englisch Name:
3H-imidazo[4,5-b]pyridine-2-carboxylic acid
Synonyma:
Pazopanib Impurity 113;2-imidazo[4,5-b]pyridinecarboxylic acid;1H-Imidazo[4,5-b]pyridine-2-carboxylic acid;3H-imidazo[4,5-b]pyridine-2-carboxylic acid
CBNumber:
CB81080742
Summenformel:
C7H5N3O2
Molgewicht:
163.13
MOL-Datei:
97640-15-8.mol

3H-imidazo[4,5-b]pyridine-2-carboxylic acid Eigenschaften

storage temp. 
2-8°C

Sicherheit

HazardClass  IRRITANT

3H-imidazo[4,5-b]pyridine-2-carboxylic acid Chemische Eigenschaften,Einsatz,Produktion Methoden

3H-imidazo[4,5-b]pyridine-2-carboxylic acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


3H-imidazo[4,5-b]pyridine-2-carboxylic acid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 27)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shenzhen Nexconn Pharmatechs Ltd
+86-755-89396905 +86-15013857715
admin@nexconn.com China 10248 58
Guangzhou Yuheng Pharmaceutical Technology Co., Ltd
+8613580539051
joe@yuhengpharm.com CHINA 21149 58
LEAPCHEM CO., LTD.
+86-852-30606658
market18@leapchem.com China 43348 58
ShangHai AmK Pharmaceutical Technology Co., Ltd. 18019252918
sale@amkchem.com China 15415 55
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd. 025-66113011 18112977050
cb6@aikonchem.com China 16687 50
SPIRO PHARMA
eric_feng1954@126.com China 9254 55
ShangHai Angti Biotechnology Co., Ltd. 13764913901
info@angtibio.com China 4550 55
Shanghai Brain Biotechnology Co., Ltd. 13564638271
sales@brain-biot.com China 2960 55
Hubei Yangxin Medical Technology Co., Ltd. 15374522761
3003392093@qq.com China 7934 55
Sichuan BaiPeng Biotechnology Co., Ltd. 028-65791793 18140026355
568470422@qq.com China 9978 58

  • 3H-imidazo[4,5-b]pyridine-2-carboxylic acid
  • 1H-Imidazo[4,5-b]pyridine-2-carboxylic acid
  • 2-imidazo[4,5-b]pyridinecarboxylic acid
  • Pazopanib Impurity 113
  • 97640-15-8
Copyright 2019 © ChemicalBook. All rights reserved